4. Generic Version of BPH Drug, Tadalafil, Being Readied for Testing in Clinical Trials
VMS Rehab Systems, Inc., reported that its generic drug subsidiary, BioPharmcor BV, is in the final development and preclinical testing stages for its generic version of tadalafil, a potential first-line treatment for men with erectile dysfunction (ED) and benign prostatic hyperplasia (BPH).
